Relation between Parkinson's Disease Severity and Cognitive Function with Monstreal Cognitive Assessment Indonesia

Amalia Noor Zafira Nasution; Aldy S  Rambe; Haflin Soraya  Hutagalung

doi:10.47353/jsocmed.v2i9.86

Relation between Parkinson's Disease Severity and Cognitive Function with Monstreal Cognitive Assessment Indonesia

Amalia Noor Zafira Nasution
Resident of Neurology Department, Faculty of Medicine, University of Utara Sumatra / Haji Adam Malik General Hospital, Medan, Indonesia
Aldy S Rambe
Staff of Neurology Department, Faculty of Medicine, University of Utara Sumatra / Haji Adam Malik General Hospital, Medan, Indonesia
Haflin Soraya Hutagalung
Staff of Neurology Department, Faculty of Medicine, University of Utara Sumatra / Haji Adam Malik General Hospital, Medan, Indonesia

Abstract

Introduction: Parkinson disease is a wide-spectrum disease that can be accompanied by motor and non-motor symptoms. Non-motor symtoms can occurred before the existance of motoric symptoms until the terimal stage of the disease, where cognitive disturbance is one of the non-motor symptoms that can decrease patient’s quality of life and increase patient’s disability. Therefore, early detection of the cognitive function is important for patients with parkinson disease. The aim of this study was to find the association between the severity of Parkinson’s disease and cognitive disturbance using the Montreal Cognitive Assesment Indonesian version (MoCA-Ina)

Method: This study used cross-sectional design. The research subject was a parkinson disease patients’ who went to Neurology Clinic at Haji Adam Malik General Hospital Medan and network hospital who met the inclusion and exclusion criteria of the study. The number of sample was 39 subjects. To determine the relationship between the severity of parkinson disease and cognitive function, the Gamma test was used.

Results: There was a significant correlation between the severity of Parkinson's disease and cognitive function (p = 0.001, r = -0.858). There was a very strong correlation between the severity of Parkinson's disease and cognitive function, and the negative correlation means the higher the severity of disease, the lower the cognitive function. From this study, the most correlated domains were delayed memory, naming (r = 0.962), orientation (r = -0.944), visuospatial (r = -0.929), abstraction (r = -0.874), language (r = -0.674), attention (r = -0.592). Delayed memory could not be statistically analyzed because delayed memory were all impaired in all subjects.

Conclusion: There was a correlation between the severity of Parkinson's disease and cognitive function with a very strong correlation strength. The cognitive function domains that correlate strongly with Parkinson's severity were delayed memory, naming, orientation, visuospatial and abstraction.

Similar Articles

Mukhamad Faried, Franciscus Ginting, Tambar Kembaren, Putri Chairani Eyanoer, Factor Influencing Mortality in Moderate - Severe Covid-19 Patients In Tertiary Hospital, Indonesia , Journal of Society Medicine: Vol. 2 No. 7 (2023): July
Qadri Fauzi Tanjung, Hendi Ishadi, The Medical Perspective of Dry Cupping and Wet Cupping: Effects and mechanisms of action , Journal of Society Medicine: Vol. 1 No. 1 (2022): October

<< < 2 3 4 5 6 7

You may also start an advanced similarity search for this article.

PDF

Published at

30. September 2023
https://doi.org/10.47353/jsocmed.v2i9.86
Issue:

Vol. 2 No. 9 (2023): September
Section:

Articles
Keywords:

Parkinson Disease Cognitive Function Moca-Ina
References:

He Y, Tian Y, Han H, Cui J, Ge X, Qin Y. et al. The path linking disease severity and cognitive function with quality of life in Parkinson’s disease: the mediating effect of activities of daily living and depression. Health Qual Life Outcomes. 2021; 19:92.

DeMaagd G, Philip A. Parkinson’s Disease and Its Management. P&T. 2015; 40 (8): 504-512.

Kouli A, Torsney KM, Kuan WL. Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. Parkinson’s Disease: Pathogenesis and Clinical Aspects. 2018: 1-25

Vasquez KA, Valverde EM, Aguilar DV, Gabarain HJH. Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination. Dement. Nuerophyschol. 2019; 13(1).

Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Chaudhuri KR. et al. Parkinson disease-associated cognitive impairment. Nature Reviews. 2021; 7: 47.

Painous C, Marti MJ. Cognitive Impairment in Parkinson’s Disease: What We Know so Far. Research and Reviews in Parkinsonism. 2020:10 7–17.

Fengler S, Kessler J, Timmermann L, Zapf A, Elben S, Wojtecki L . et al. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting. PLoS ONE. 2016; 11(7): e0159318.

Wakamori T , Agari T , Yasuhara T , Kameda M , Konso A , Shinko A. et al. Cognitive functions in Parkinson's disease: Relationship to disease severity and hallucination. Kibi International University. 2014:1-2

Tarukbua FR , Tumewah R, Maja J. Gambaran functional cognitive impairment of parkinsonism at the Polyclinic Saraf RSUP Prof. Dr. A.S. RD Kandou Manado. e-Clinic Journal. 2016; 4(1): 1-7

Brett B. Neurocognitive Functioning in Parkinson’s Disease Patients: Assessing the Unique Contributions of Depression and Fatique While Controlling for Disease Severity. The University of Memphis. 2018: 1-29.

Hanum L. Hubungan Derajat Penyakit Parkinsond engan Gangguan Fungsi Kognitif Menggunakan Instrumen Montreal Cognitive Assessment versi Indonesia. Fakultas Kedokteran Universitas Andalas. 2019: 1-3.

Nazem S, Sideorwf AD, Duda JE. Montreal Cognitive Assesment Performance in Patients with Parkinson’s Disease with “Normal” Global Cognition According to MMSE Score. J AM Geriatr Soc. 2009; 57: 304-8.

Vingerhoets G, Verleden S, Santens P. Predictors of Cognitive Impairment in Advanced Parkinson’s Disease. J Neurol. 2003. Neurosurg Psychiatry; 74: 793-6

Nindela, Rini , Tambun, Oktavianus and Marisdina, Selly, Bahar, Erial. Cognitive Impairment in Parkinson's disease Patients: a Descriptive Study. Movement Disorders. 2021; 36 (supp. 1): 296-297.

Desravima MB. The relationship between the degree of Parkinson's disease and cognitive dysfunction using the Mini Mental State Examination (MMSE) instrument. Diploma thesis, Andalas University. 2019

Watson GS, Leverenx JB. Profile of Cognitive Impairment in Parkinson's Disease . Brain Pathol. 2010; 20(3): 640-645.

Pradyaning PE, Widyastuti K, Laksmidewi AA . Profile of Neurocognitive Disorders in Parkinson's Disease Patients at Referral Hospitals in Despansar City in 2018. Callosum Neurology. Denpasar. 2020.

Uc EY, Mc Dermot MP, Marder KS. Incidence of and Risk Factors for Cognitive Impairment in an Early Parkinson Disease Clinica Trial Cohor. Neurology. 2009; 73(18): 1469-77.

Silalahi PY. Korelasi Gangguan Fungsi Kognitif dengan Stadium Penyakit Parkinson. Udayana University. 2012.

Biundo R, Weis L, Antonini A. Cognitive Decline in Parkinson’s Disease: The Complex Picture. Npj Park Dis. 2016;2(1):16018.

Adwani S, Yadav R, Kumar K. Neuropsychological Profile in Early Parkinson’s Disease: Comparison between Patients with Right Side Onset Versus Left Side Onset of Motor Symptoms. Ann Indian Acad Neurol. 2016; 19 (1): 74-8.

Broeders M, Velsboer DC, de Bie R. Cognitive change in Newly-Diagnosed Patients with Parkinson’s Disease: a 5-year Follow-up Study. J iNt Neuropsychol Soc. 2013; 19 (6): 695-708.
Share:

Z

Nasution, A. N. Z., Rambe , A. S. ., & Hutagalung , H. S. . (2023). Relation between Parkinson’s Disease Severity and Cognitive Function with Monstreal Cognitive Assessment Indonesia. Journal of Society Medicine, 2(9), 296–301. https://doi.org/10.47353/jsocmed.v2i9.86